1h Free Analyst Time
The global electronic skin patches market is expected to grow at a CAGR of 20.17% during 2022-2027. Speak directly to the analyst to clarify any post sales queries you may have.
MARKET INSIGHTS
- The significant factors contributing to the growth of the electronic skin patches market include the rise in the need for continuous monitoring of physiological parameters, growing penetration of wearable devices and mobile platforms for healthcare monitoring, development of innovative skin patches, high demand for remote patient monitoring, an emerging trend of digital tattoos, presence of supporting initiatives and reimbursement policies, and a growing number of start-ups developing electronic skin patches.
- Electronic skin patches anchor a device on the patient's or user's skin to achieve a specific function. These patches are attached to a user's skin and incorporated with sensors, actuators, processors, and communication technology, which allow the device to connect to the internet and turn it smart. Several significant application areas are now profoundly impacting health and quality of life. In particular, cardiovascular monitoring and diabetes management has been growing exponentially to create billions of annual revenues.
- Electronic skin patches are one of the latest waves in health monitoring; their non-intrusive design means they are comfortable and discrete. These patches include sweat, axillary temperature, motion, biopotential (TENS, EMS) patches, and devices across various sectors and product categories. In cardiovascular monitoring, these devices range from traditional ECG options and monitoring devices for inpatients and outpatients to specific products such as Holter monitors, mobile cardiac telemetry devices, and other event monitors.
MARKET TRENDS & OPPORTUNITIES
Growing Number of Start-ups and Rise in the Development of Innovative Skin Patches
- With the growing demand for technological innovations in the healthcare field, several start-ups are emerging to stay ahead of the technology curve to strengthen their competitive advantage in the electronic skin patches market. A few interesting start-ups and universities are working to bring advanced electronic skin sensor patches into the market. For instance, XSENSIO SA has developed next-generation wearable devices to track biochemical information on the wearer's skin surface. Scientists at the Georgia Institute of Technology have developed wireless wearable devices for measuring heart rate, electrocardiogram, respiratory rate, and motion activity. Some scientists have also developed a flexible, wearable patch detecting blood-alcohol levels from the user's sweat.
High Need for Constant Physiological Monitoring and Treatment for Hospitalized Patients
- The growing burden of acute or chronic conditions has increased the need for continuous monitoring of both inpatients and outpatients. The major causes of death worldwide are due to heart diseases, cancers, diabetes, chronic lower respiratory syndrome, stroke, cerebrovascular diseases, viral infections, and others. Cardiovascular diseases are one of the leading causes of death worldwide, taking around 17.9 million lives each year. This increased the number of patients needing to constantly monitor heart rate, pulse rate, electrocardiogram, and other parameters related to the heart. The electronic skin patches market has emerged to monitor such physiological parameters for heart-related diseases and various other conditions.
Remote Patient Monitoring Driving the Adoption of Electronic Skin Patches
- Remote patient monitoring uses innovative technology tools to collect and track patient data outside standard medical settings. With an increase in the prevalence of various diseases, many healthcare providers are shifting to implementing remote patient monitoring, especially in conditions such as elderly patients, pandemics, and others. The adoption of remote patient monitoring is increasing the use of electronic skin patches to transfer patient information directly to the healthcare provider or enter into the electronic medical records boosting the electronic skin patches market. Cardiology was one of the first therapy areas to introduce remote patient monitoring into standard practice. This sector streamlines doctor-hospital visits by remotely switching monitors between compact cardiac monitoring devices during the monitoring period.
Increase in Adoption of Healthcare Applications & Smart Wearables
- Many users are increasingly adopting connected wearable medical devices due to their various advantages, such as continuous monitoring, prediction of health problems and providing alerts, a collection of detailed real-time longitudinal data, and helping educate and empower patients to take control of their health. These devices are being incorporated and connected to electronic skin patches, providing ease of use, and contributing to the growth of the global electronic skin patch market. Software applications in mobiles or smart watches are associated with these patches to send data directly and help monitor the users’ health.
SEGMENTATION ANALYSIS
INSIGHTS BY APPLICATION
The global electronic skin patches market based on applications includes diabetes management, general patient monitoring, cardiovascular monitoring, and others. Diabetes management accounts for the highest share of 43.51% and is estimated to reach USD 18.10 billion by 2027 in the global market.- Diabetes Management: This includes electronic skin patches used to manage diabetes with continuous glucose monitoring and insulin pumps.
- General Patient Monitoring: This includes electronic skin patches used to monitor various physiological parameters and majorly vitals such as temperature, heart rate, pulse rate, and respiratory rate.
- Cardiovascular Monitoring: This includes electronic skin patches used in monitoring the activity of the heart by ECG, EKG, Holter monitoring, mobile cardiac telemetry, and ambulatory cardiac monitoring.
- Others: This includes electronic skin patches used for various purposes such as cosmetics, sports, fitness & wellness, wound care, electrical stimulation, imaging, fetal monitoring, sleep tracking, stress, and pharmaceuticals.
Segmentation by Application
- Home Care Settings
- Hospitals
- Physician Offices & Specialty Clinics
- Others
INSIGHTS BY END-USER
Based on the end-user, the global electronic skin patches market includes home care settings, hospitals, physician offices & specialty clinics, and others. In 2021, home care settings accounted for the global market's highest share of 42.80%.- Home Care Settings: This includes home care providers and individuals using electronic skin patches to monitor and treat various conditions.
- Hospitals: This includes hospitals that use electronic skin patches for monitoring and treating various conditions.
- Physician Offices & Specialty Clinics: This includes physician offices & specialty clinics, diagnostic centers, sleep labs & clinics, and physiotherapy & rehabilitation centers that use electronic skin patches for monitoring and treating various conditions.
- Others: This includes cosmetic clinics, sports, health and wellness centers, pharma & biotech companies, ambulatory surgical centers, and academic & research institutes that use electronic skin patches for monitoring and treating various conditions.
Segmentation by End-User
- Home Care Settings
- Hospitals
- Physician Offices & Specialty Clinics
- Others
GEOGRAPHICAL OVERVIEW
North America accounts for the highest share of 47.59% in the global electronic skin patches market. North America is the major revenue contributor in the global market due to various factors involved in its growth that including the rising prevalence of cardiac disorders and diabetes, the presence of advanced healthcare infrastructure, a rise of wearable devices for healthcare monitoring, a surge in the use of IoT based applications, miniaturization of sensors used in medical devices, a growing trend for maintaining personal health and fitness, and growing demand for skin patches for drug delivery.Further, the U.S. accounts for 94.11% of North America's electronic skin patches market share. The growing demand for electronic skin patches across the country is likely growing with the rise in chronic conditions such as cardiovascular diseases and diabetes, which require constant monitoring of various parameters such as heart rate, blood glucose levels, blood pressure, and others. Due to this, most patients are using electronic skin patches that help monitor various physiological factors. For instance, in the U.S., for every 36 seconds, a person dies from cardiovascular disease. The increasing prevalence of various diseases is a significant factor contributing to the growing adoption of remote monitoring devices.
Europe has the second largest revenue share compared to other regions owing to the highly sophisticated healthcare infrastructure and high adoption and awareness of the advantages of electronic skin patches over conventional monitoring options. APAC is likely to be an emerging region in the global electronic skin patches market, with most people focusing on maintaining their physical health and continuously monitoring their physiological parameters. Latin America, the Middle East & Africa accounted for minimal shares in the global electronic skin patches market.
Segmentation by Geography
- APAC
- China
- Japan
- India
- South Korea
- Australia
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
COMPETITIVE LANDSCAPE
The competitive landscape in the global electronic skin patch market is currently intensifying due to the rapidly changing technological environment in the healthcare industry. Vendors operating the market are pursuing various strategies to provide the impetus for growth over the next few years.These market participants adopt collaboration, partnerships, mergers, acquisitions, product launches, and other strategies. For instance, Philips acquired BioTelemetry, a leading player in the mobile cardiac telemetry market, in February 2021.
Large medical device companies are adopting an acquisition strategy to invest or partner with many emerging vendors to diversify their product portfolio and strengthen their presence in the overall market. For instance, iRhythm Technologies deployed ZioAT and ZioXT virtual platforms to help doctors treat a patient's heart using telemetry during the COVID-19 pandemic in April 2020.
The global electronic skin patches market is likely to get highly dynamic with the presence of major international, regional, and a handful of local vendors offering electronic skin patches. Abbott, Dexcom, General Electric Company, and Koninklijke Philips are vendors that contributed to a major share of the global electronic skin patches market.
Key Vendors
- Abbott
- Dexcom
- General Electric Company
- Koninklijke Philips N.V.
Other Prominent Vendors
- Menarini Diagnostics
- Bardy Diagnostics
- Benware Medical
- Bittium
- Bloomlife
- Blue Spark Technologies
- BORSAM Biomedical Instruments
- Boston Scientific
- Cardiomo
- DMS-Service
- Epicore Biosystems
- FUKUDA DENSHI
- Gamastech
- Holst Centre
- Insulet
- iRhythm Technologies
- Isansys
- LCR Hallcrest
- LifeSignals
- Liv ApS
- Medicomp
- Medidata
- Medicsensors
- Medtrum Technologies
- Natures Frequencies
- Nemaura Medical
- OMRON Healthcare
- Onera Technologies B.V.
- PAINMASTER
- QT Medical
- Quad Industries
- Smith+Nephew
- SpotSee
- The Surgical Company
- Theranica Bio-Electronics
- The Scott Fetzer Company
- Virility Medical
- VitalConnect
- VivaLNK
- Vivomi
- WearOptimo
- Xsensio
KEY QUESTIONS ANSWERED
1. What is the expected growth of the global electronic skin patches market?2. What is the growth rate of the global electronic skin patches market?
3. What are the latest trends in the global electronic skin patches market?
4. Who are the key players in the global electronic skin patches market?
5. Which region dominates the global electronic skin patches market share?
Table of Contents
1 Research Methodology2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Application
4.3.2 Market Segmentation by End-User
4.3.3 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Premium Insights
7.1 Global Electronic Skin Patches Market
7.1.1 Growing Number of Startups & Innovative Skin Patches
7.1.2 High Need for Constant Physiological Monitoring & Treatment for Hospitalized Patients
7.1.3 Remote Patient Monitoring Driving Adoption of Electronic Skin Patches
7.1.4 Increase in Adoption of Healthcare Applications & Smart Wearables
7.1.5 Market Segmentation of Global Electronic Skin Patches Market
7.1.6 Competitive Landscape
8 Introduction
8.1 Overview
9 Market Opportunities & Trends
9.1 Increasing Start-Ups & Universities Developing E-Skin Patches
9.2 Rise of Innovative Electronic Skin Patches
9.3 Emerging Trend of Using Digital Tattoos for Health Monitoring
9.4 High Demand for Remote Patient Monitoring
10 Market Growth Enablers
10.1 Rising Need for Continuous Physiological Monitoring & Treatment
10.2 Presence of Supporting Initiatives, Regulations & Reimbursement Policies
10.3 Increasing Penetration of Wearable Devices & Mobile Healthcare Platforms
10.4 Rise in Usage of Electronic Skin Patches for Drug Delivery & Cosmetics
11 Market Growth Restraints
11.1 Limitations Associated With Use of Electronic Skin Patches
11.2 Data Security & Privacy Issues With E-Skin Patches
11.3 High Cost of Various Electronic Skin Patches
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Insights by Application
12.2.2 Insights by End-User
12.2.3 Insights by Geography
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Diabetes Management
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Diabetes Management: Market by Geography
13.4 General Patient Monitoring
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 General Patient Monitoring: Market by Geography
13.5 Cardiovascular Monitoring
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Cardiovascular Monitoring: Market by Geography
13.6 Others
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Others: Market by Geography
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Home Care Settings
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Home Care Settings: Market by Geography
14.4 Hospitals
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Hospitals: Market by Geography
14.5 Physician Offices & Specialty Clinics
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Physician Offices & Specialty Clinics: Market by Geography
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Others: Market by Geography
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.2.1 North America: Application
16.2.2 North America: End-User
16.3 Key Countries
16.3.1 Us: Market Size & Forecast
16.3.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.2.1 Europe: Application
17.2.2 Europe: End-User
17.3 Key Countries
17.3.1 Germany: Market Size & Forecast
17.3.2 France: Market Size & Forecast
17.3.3 Uk: Market Size & Forecast
17.3.4 Italy: Market Size & Forecast
17.3.5 Spain: Market Size & Forecast
18 Apac
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Apac: Application
18.2.2 Apac: End-User
18.3 Key Countries
18.3.1 Japan: Market Size & Forecast
18.3.2 China: Market Size & Forecast
18.3.3 India: Market Size & Forecast
18.3.4 South Korea: Market Size & Forecast
18.3.5 Australia: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 Latin America: Application
19.2.2 Latin America: End-User
19.3 Key Countries
19.3.1 Brazil: Market Size & Forecast
19.3.2 Mexico: Market Size & Forecast
19.3.3 Argentina: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 Middle East & Africa: Application
20.2.2 Middle East & Africa: End-Users
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 South Africa: Market Size & Forecast
20.3.3 Saudi Arabia: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Abbott in Electronic Skin Patches Market
21.2.2 Dexcom in Electronic Skin Patches Market
21.2.3 General Electric Company in Electronic Skin Patches Market
21.2.4 Koninklijke Philips N.V in Electronic Skin Patches Market
22 Key Company Profiles
22.1 Abbott
22.1.1 Business Overview
22.1.2 Abbott in Electronic Skin Patches Market
22.1.3 Product Offerings
22.1.4 Key Strategies
22.1.5 Key Strengths
22.1.6 Key Opportunities
22.2 Dexcom
22.2.1 Business Overview
22.2.2 Dexcom in Electronic Skin Patches Market
22.2.3 Product Offerings
22.2.4 Key Strategies
22.2.5 Key Strengths
22.2.6 Key Opportunities
22.3 General Electric Company
22.3.1 Business Overview
22.3.2 General Electric Company in Electronic Skin Patches Market
22.3.3 Product Offerings
22.3.4 Key Strategies
22.3.5 Key Strengths
22.3.6 Key Opportunities
22.4 Koninklijke Philips N.V.
22.4.1 Business Overview
22.4.2 Koninklijke Philips N.V. in Electronic Skin Patches Market
22.4.3 Product Offerings
22.4.4 Key Strategies
22.4.5 Key Strengths
22.4.6 Key Opportunities
23 Other Prominent Vendors
23.1 A. Menarini Diagnostics
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Bardy Diagnostics
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Benware Medical
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Bittium
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Bloomlife
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Blue Spark Technologies
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Borsam Biomedical Instruments Co.
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Boston Scientific
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Cardiomo
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 Dms-Service
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Epicore Biosystems
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 Fukuda Denshi
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Gamastech
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Holst Centre
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Insulet
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Irhythm Technologies
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 Isansys
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Lcr Hallcrest
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Lifesignals
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Liv Aps
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Medicomp
23.21.1 Business Overview
23.21.2 Product Offerings
23.22 Medidata
23.22.1 Business Overview
23.22.2 Product Offerings
23.23 Medicsensors S.L
23.23.1 Business Overview
23.23.2 Product Offerings
23.24 Medtrum Technologies
23.24.1 Business Overview
23.24.2 Product Offerings
23.25 Natures Frequencies
23.25.1 Business Overview
23.25.2 Product Offerings
23.26 Nemura Medical
23.26.1 Business Overview
23.26.2 Product Offerings
23.27 Omron Healthcare
23.27.1 Business Overview
23.27.2 Product Offerings
23.28 Onera Technologies B.V.
23.28.1 Business Overview
23.28.2 Product Offerings
23.29 Painmaster
23.29.1 Business Overview
23.29.2 Product Offerings
23.30 Qt Medical
23.30.1 Business Overview
23.30.2 Product Offerings
23.31 Quad Industries
23.31.1 Business Overview
23.31.2 Product Offerings
23.32 Smith+Nephew
23.32.1 Business Overview
23.32.2 Product Offerings
23.33 Spotsee
23.33.1 Business Overview
23.33.2 Product Offerings
23.34 the Surgical Company
23.34.1 Business Overview
23.34.2 Product Offerings
23.35 Theranica Bio-Electronics
23.35.1 Business Overview
23.35.2 Product Offerings
23.36 the Scott Fetzer Company
23.36.1 Business Overview
23.36.2 Product Offerings
23.37 Virility Medical
23.37.1 Business Overview
23.37.2 Product Offerings
23.38 Vital Connect
23.38.1 Business Overview
23.38.2 Product Offerings
23.39 Vivalnk
23.39.1 Business Overview
23.39.2 Product Offerings
23.40 Vivomi
23.40.1 Business Overview
23.40.2 Product Offerings
23.41 Wearoptimo
23.41.1 Business Overview
23.41.2 Product Offerings
23.42 Xsensio
23.42.1 Business Overview
23.42.2 Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market by Application
25.1.1 North America: Application Segmentation
25.1.2 Europe: Application Segmentation
25.1.3 Apac: Application Segmentation
25.1.4 Latin America: Application Segmentation
25.1.5 Middle East & Africa: Application Segmentation
25.2 Market by End-User
25.2.1 North America: End-User Segmentation
25.2.2 Europe: End-User Segmentation
25.2.3 Apac: End-User Segmentation
25.2.4 Latin America: End-User Segmentation
25.2.5 Middle East & Africa: End-User Segmentation
25.3 Market by Geography
25.3.1 Diabetes Management: Geography Segmentation
25.3.2 General Patient Monitoring: Geography Segmentation
25.3.3 Cardiovascular Monitoring: Geography Segmentation
25.3.4 Others Applications: Geography Segmentation
25.3.5 Home Care Settings: Geography Segmentation
25.3.6 Hospitals: Geography Segmentation
25.3.7 Physician Offices & Specialty Clinics: Geography Segmentation
25.3.8 Other End-Users: Geography Segmentation
26 Appendix
26.1 Abbreviations
Companies Mentioned
- Abbott
- Dexcom
- General Electric Company
- Koninklijke Philips N.V.
- Menarini Diagnostics
- Bardy Diagnostics
- Benware Medical
- Bittium
- Bloomlife
- Blue Spark Technologies
- BORSAM Biomedical Instruments
- Boston Scientific
- Cardiomo
- DMS-Service
- Epicore Biosystems
- FUKUDA DENSHI
- Gamastech
- Holst Centre
- Insulet
- iRhythm Technologies
- Isansys
- LCR Hallcrest
- LifeSignals
- Liv ApS
- Medicomp
- Medidata
- Medicsensors
- Medtrum Technologies
- Natures Frequencies
- Nemaura Medical
- OMRON Healthcare
- Onera Technologies B.V.
- PAINMASTER
- QT Medical
- Quad Industries
- Smith+Nephew
- SpotSee
- The Surgical Company
- Theranica Bio-Electronics
- The Scott Fetzer Company
- Virility Medical
- VitalConnect
- VivaLNK
- Vivomi
- WearOptimo
- Xsensio
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 268 |
| Published | January 2023 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 9.57 Billion |
| Forecasted Market Value ( USD | $ 28.82 Billion |
| Compound Annual Growth Rate | 20.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 46 |
